Related Experiment Video
Updated: Nov 12, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop
Qinkai Zhang1, Xunzhu Zhou1, Maoping Wan1
1Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China.
Abstract:
Ovarian cancer (OC) causes more deaths than any other gynecological cancer. Many cellular pathways have been elucidated to be associated with OC development and progression. Specifically, the insulin-like growth factor 1 receptor/insulin receptor substrate 1 (IGF1R/IRS1) pathway participates in OC development. Moreover, accumulating evidence has shown that microRNA deregulation contributes to tumor initiation and progression. Here, our study aimed to investigate the molecular functions and regulatory mechanisms of miR-150, specifically, in OC. We found that the expression of miR-150-5p/3p and their precursor, mir-150, was downregulated in OC tissues; lower mir-150 levels were associated with poor OC patient outcomes. Ectopic mir-150 expression inhibited OC cell growth and metastasis in vitro and in vivo. Furthermore, both IRS1 and IGF1R were confirmed as direct targets of miR-150-5p/3p, and the miR-150-IGF1R/IRS1 axis exerted antitumor effects via the PI3K/AKT/mTOR pathway. Forkhead box protein 3 (FoxP3) positively regulated the expression of miR-150-5p/3p by binding to the mir-150 promoter. In turn, the PI3K/AKT/mTOR pathway downregulated FoxP3 and miR-150-5p/3p. Taken together, these findings indicate that a complex FoxP3-miR-150-IGF1R/IRS1-PI3K/AKT/mTOR feedback loop regulates OC pathogenesis, providing a novel mechanism for miR-150 as a tumor suppressor miRNA in OC.
Insights
MicroRNA-150 (miR-150) acts as a tumor suppressor in ovarian cancer (OC) by inhibiting the IGF1R/IRS1 pathway. Its downregulation correlates with poor outcomes, while restoration suppresses OC growth and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Ovarian cancer (OC) is a leading cause of gynecological cancer deaths.
- Deregulation of microRNAs (miRNAs) and the insulin-like growth factor 1 receptor/insulin receptor substrate 1 (IGF1R/IRS1) pathway are implicated in OC progression.
Purpose of the Study:
- To investigate the role and regulatory mechanisms of miR-150 in ovarian cancer.
- To elucidate the molecular functions of miR-150 in OC development and progression.
Main Methods:
- Analysis of miR-150 expression in OC tissues and correlation with patient outcomes.
- In vitro and in vivo experiments to assess the effects of ectopic miR-150 expression on OC cells.
- Luciferase reporter assays and Western blotting to identify direct targets and signaling pathways involved.
- Chromatin immunoprecipitation and promoter analysis to determine upstream regulators.
Main Results:
- miR-150 expression was downregulated in OC tissues and associated with poor patient prognosis.
- Restoring miR-150 expression inhibited OC cell proliferation, migration, and invasion.
- IGF1R and IRS1 were identified as direct targets of miR-150, with the miR-150-IGF1R/IRS1 axis suppressing the PI3K/AKT/mTOR pathway.
- Forkhead box protein 3 (FoxP3) positively regulated miR-150 expression, forming a feedback loop with the PI3K/AKT/mTOR pathway.
Conclusions:
- miR-150 functions as a tumor suppressor miRNA in ovarian cancer.
- A novel feedback loop involving FoxP3, miR-150, IGF1R/IRS1, and the PI3K/AKT/mTOR pathway regulates OC pathogenesis.
- These findings offer potential therapeutic targets for ovarian cancer treatment.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
MicroRNAs
TGF - β Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

